PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Ziram

EC / List no: 205-288-3 CAS no: 137-30-4
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Comprehensive
Status
Follow-up
Decision date
16-lut-2022
Decision
Latest update
27-lis-2023
Additional information
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Denmark
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
High RCR
Year
2012
Status
Information requested
Conclusion document
Latest update
29-mar-2023
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Denmark
Status
Under development under SEV
Outcome
Under development (SEV)
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
03-lut-2012
Date of hazard assessment
Latest update
03-lut-2021
More information View
Regulatory risk management
Assessment of regulatory needs
ARN 1
Authority
ECHA
Concern
Status
Under development
Follow-up
Other action
Foreseen regulatory need
Restriction
Summary document
Group name
dithiocarbamate complexes
Remarks
Date of intention
06-lis-2020
Date of assessment
24-cze-2021
Latest update
05-lip-2023
More information View
ARN 2
Authority
Denmark
Concern
Endocrine disruption
Status
Under development
Follow-up
No suggestion yet
Foreseen regulatory need
Summary document
Group name
Remarks
Date of intention
03-lut-2012
Date of assessment
Latest update
24-lis-2021
More information View

List entry date: 14-sty-2016

Export search results to: